Tirzepatide - First in a new class of diabetes medication (Part 1)

madman

Super Moderator
Tirzepatide is a new class of medication for t2d that activates GIP and glp1 receptors. Endocrinologist Dr. Thomas Blevins (MD, FACE) from Texas Diabetes and Endocrinology, Austin, TX, presents data and practical information for clinicians.



Screenshot (18543).png
 


 

ExcelMale Newsletter Signup

Online statistics

Members online
0
Guests online
343
Total visitors
343

Latest posts

Beyond Testosterone Podcast

Back
Top